Evidence map›Paper›PMID 30464865›Full record

ArticleJournal of general and family medicine2018

Clinical features and seasonal variations in the prevalence of macrolide-resistant

Yusaku Akashi, Daisuke Hayashi, Hiromichi Suzuki, Masanari Shiigai, Koji Kanemoto, Shigeyuki Notake, Takumi Ishiodori, Hiroichi Ishikawa, Hironori Imai

Abstract read
In one paragraph

Article in Journal of general and family medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Clinical characteristics and associated factors of macrolide-resistant mycoplasma pneumoniae pneumonia in children: a systematic review and meta-analysis.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025
    Pooled it
  2. Pooled it
  3. Doxycycline for Macrolide-ResistantInfection and drug resistance · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. The epidemic characteristics ofMicrobiology spectrum · 2024
    Article
  9. Macrolide resistance ofEpidemiology and infection · 2024
    Article
  10. SevereAfrican journal of thoracic and critical care medicine · 2024
    Article
  11. Article
  12. Article
  13. RefractoryJournal of clinical medicine · 2022
    Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yusaku AkashiDivision of Infectious Diseases Department of Medicine Tsukuba Medical Center Hospital Tsukuba Ibaraki Japan.ORCID 0000-0001-9789-8301
Daisuke HayashiDepartment of Pediatrics Tsukuba Medical Center Hospital Tsukuba Ibaraki Japan.
Hiromichi SuzukiDivision of Infectious Diseases Department of Medicine Tsukuba Medical Center Hospital Tsukuba Ibaraki Japan.
Masanari ShiigaiDepartment of Radiology Tsukuba Medical Center Hospital Tsukuba Ibaraki Japan.
Koji KanemotoDepartment of Respiratory Medicine Tsukuba Medical Center Hospital Tsukuba Ibaraki Japan.
Shigeyuki NotakeDepartment of Clinical Laboratory Tsukuba Medical Center Hospital Tsukuba Ibaraki Japan.
Takumi IshiodoriDivision of Infectious Diseases Department of Medicine Tsukuba Medical Center Hospital Tsukuba Ibaraki Japan.
Hiroichi IshikawaDepartment of Respiratory Medicine Tsukuba Medical Center Hospital Tsukuba Ibaraki Japan.
Hironori ImaiDepartment of Pediatrics Tsukuba Medical Center Hospital Tsukuba Ibaraki Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background

methodsThe monthly prevalence of MRM in

results

conclusionsThe determination rate of MRM varied widely throughout the year, and our study demonstrated the challenges in predicting

Indexed as

GENECUBEmacrolide resistanceMycoplasma pneumoniaepoint‐of‐care molecular testingprevalence

Identifiers

PMID30464865
PMCPMC6238234

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.